U
UTHR
United Therapeutics Corp.
516.68
-1.85-0.36%After Hours: 516.68 0.00 0.00%19:30 08/26 EDT
OPEN/PREV CLOSE513.98/516.68
TODAY RANGE511.00-531.76
VOL391.00K
MARKET CAP22.64B
52 WEEK RANGE302.19-609.35
AVG VOL (3M)507.00K
% TURNOVER0.91%
TURNOVER--
P/E (TTM)18.88
% RANGE4.02%
EPS(TTM)27.96
P/E(FORWARD)20.27
P/B3.520
BVPS149.97
DIVIDEND--
P/S7.24
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP22.17B
SHARES OUTSTANDING42.89M
NEXT EARNINGS10/27-11/02
FREE FLOAT41.99M
LOT SIZE1
EX-DATE09/23/2009
News
Press Releases
Financial Reports
Profile
TipRanks·10h ago
Trump Trade: U.S. considering new semiconductor tariffs
Simply Wall St·1d ago
United Therapeutics (UTHR) Faces A Valuation Test After FDA Accepts Ralinepag NDA
TipRanks·3d ago
United Therapeutics announces FDA accepted NDA for ralinepag
Simply Wall St·5d ago
Did Full Enrollment of TETON-PPF Just Shift United Therapeutics' (UTHR) Investment Narrative?
Seeking Alpha·5d ago
Tracking Renaissance Technologies (RenTec) 13F Portfolio - Q2 2026 Update
NASDAQ·08/19 18:40
Can Yutrepia's Strong Growth Drive Liquidia's PAH Expansion?
Simply Wall St·08/18 16:25
United Therapeutics (UTHR) Could Be 24% Undervalued On TETON PPF Enrollment Progress
Seeking Alpha·08/17 18:10
Quant ratings on Renaissance Technologies top holdings: NVDA, META, INTC
TipRanks·08/17 11:06
United Therapeutics announces full enrollment in TETON-PPF study
Simply Wall St·08/13 14:27
United Therapeutics (UTHR) Stock Looks Undervalued Despite Fresh NDA Filings
TipRanks·08/10 17:44
3 ‘Perfect Ten’ Healthcare Stocks That Analysts Rate as a Strong Buy
Same Industry
Name/Symbol
Change%
Price